OR WAIT null SECS
August 11, 2023
Novartis has completed its acquisition of biopharma company Chinook Therapeutics.
August 01, 2023
Biogen’s acquisition of Reata will grant them access to Reata’s FDA-approved treatment for Friedreich’s ataxia.
July 21, 2023
The proposed spin-off of Sandoz into an independent entity has been approved by Novartis’ board of directors.
July 20, 2023
Novartis’ acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.
June 08, 2023
The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.
May 24, 2023
UK government supports AMR research with significant cash injection, provided through the Global AMR Innovation Fund (GAMRIF).
May 18, 2023
Waters Corporation expected to boost growth in bioanalytical characterization for new modalities with acquisition of Wyatt Technology.
May 16, 2023
In a brief, the Federal Trade Commission cited concerns about the acquisition resulting in an increased monopoly on Amgen’s newly acquired thyroid eye disease and chronic refractory gout treatments.
May 10, 2023
Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.
April 18, 2023
Merck will acquire Prometheus Biosciences, a clinical-stage biotechnology company specializing in immune-mediated diseases, at a total equity valuation of $10.8 billion.